UAE healthcare sector advances in 2025 with rare surgeries, innovative treatments
18 Apr 2025 14:13
ABU DHABI (WAM)The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various specialties.The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of care.Kings College Hospital London Dubai announced on Thursday the city's first liver transplant on an infant, a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). The child was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure.Cleveland Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery.In January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one robot.Corniche Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive medicine.The UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy.The Emirates Health Services (EHS) unveiled two innovative projects – an Artificial Heart Transplantation and an Pancreatic Cell Transplantation at Arab Health 2025 in January.In April, the Department of Health – Abu Dhabi also completed a groundbreaking clinical trial in Abu Dhabi. The treatment, StromaForte, has shown a favourable safety profile and significant therapeutic potential for knee osteoarthritis, marking a significant step in evaluating cell-based therapies for degenerative joint diseases.M42, a leading global health technology company powered by AI, is meanwhile set to build a heavy ion therapy facility at Cleveland Clinic Abu Dhabi, bringing one of the most advanced and effective cancer treatment technologies to the Middle East.
During Abu Dhabi Global Healthcare Week 2025, which concluded on Thursday, Cleveland Clinic Abu Dhabi also unveiled initiatives and new technologies to improve cancer patient care, including an innovative remote monitoring programme, using the BioButton wearable device, for cancer patients at the Fatima Bint Mubarak Centre.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
14 hours ago
- The National
Historic Sharjah site is candidate for Unesco World Heritage status
A site in Sharjah where evidence of human habitation dating back more than 210,000 years has been found is a candidate for Unesco World Heritage status. Faya, an ancient archaeological site of huge significance in the Arabian Peninsula, is among 30 sites being considered by the UN's cultural body. Unesco's World Heritage committee will now make a decision at its 47th session to be held from July 7 to 16 in Paris. The Sharjah site is what is known as a palaeolandscape, providing insights into how early humans lived, migrated, and adapted to environments. Sheikha Bodour Al Qasimi is the official ambassador of the emirate's Unesco World Heritage nomination file. 'Faya offers one of the oldest and most complete records of early human presence in Arabia, dating back over 210,000 years - a living archive that deepens our understanding of who we are, where we came from, and how we have learnt to survive,' said Sheika Bodour, in remarks carried by state news agency Wam last month. 'The Faya palaeolandscape's nomination for Unesco World Heritage status highlights the importance of preserving these ancient sites, not only for their historical value but for their potential to educate future generations. As ambassador, I see this nomination as an opportunity to elevate Faya as a shared inheritance for all people around the world." Research pays off The Faya Range, a chain of limestone outcrops known in Arabic as jebels, can be considered a natural barrier between the Rub Al Khali desert to its west and the Dhaid-Madam plain to its east. The area is rich in resources such as flint and freshwater springs, which made human settlements there. There is evidence of human tools, life and burials. Scientists say the environment and people's way of living changed over thousands of years in the area. 'Over 30 years of meticulous research and collaboration led by our national mission and experts with international experts have revealed 18 distinct archaeological layers from the Stone Age, bringing to light an intricate history of human evolution, adaptation and survival right here in Sharjah,' said Eisa Yousif, director of the Sharjah Archaeology Authority, in remarks also carried by Wam. 'As we advance Faya's Unesco World Heritage nomination, it is important to emphasise that our collaborative efforts have made this a global project; one that connects the past with the present more strongly, adding to the rich global corpus of archaeological discoveries. This property, therefore, holds immense value for the world - not just Sharjah and the UAE," he added. Faya was added to Unesco's tentative list in 2023. The UAE has developed a comprehensive management plan for the Faya Palaeolandscape, which will guide its conservation, research, and visitor engagement from 2024 to 2030, Wam said. This plan aligns with Unesco's World Heritage standards, ensuring that the site is preserved while also allowing for continued exploration and education. The UAE has currently one site on the heritage list. The cultural sites of Al Ain (Hafit, Hili, Bidaa Bint Saud and Oases Areas) were collectively added in 2011. Unesco's meeting, meanwhile, will also see it examine the extension of two sites already on the list and will review of the state of conservation of 248 sites already inscribed. To date, it has inscribed 1,223 cultural and natural sites in 168 countries on the World Heritage list.
Zawya
14 hours ago
- Zawya
IntelliDent AI and Manipal Academy of Higher Education sign strategic MoU to transform healthcare through AI
IntelliDent AI, a Dubai-based healthtech innovator transforming dentistry through artificial intelligence, has signed a Memorandum of Understanding (MoU) with the Manipal Academy of Higher Education (MAHE), India—an Institution of Eminence and global academic leader. This strategic three-year partnership aims to accelerate advancements in AI-powered oral healthcare through collaborative research, education, and entrepreneurship. The MoU, executed on behalf of MAHE's Manipal College of Dental Sciences (MCODS), Mangalore, lays the foundation for academic-industry cooperation focused on developing future-ready dental AI solutions and equipping students with the technical and entrepreneurial skills to lead the next era of digital healthcare. Key Pillars of the Collaboration: Joint Research Programs: MAHE and IntelliDent will co-develop research initiatives in AI-driven diagnostics, public health, and healthcare innovation—contributing to academic publications, patents, and whitepapers. Training & Internships: MAHE students will gain hands-on exposure through internships and mentorships at IntelliDent, supported by industry insights, guest lectures, and workshops. Entrepreneurial Development: The collaboration will foster cohort-based learning modules, innovation hackathons, and startup support to accelerate the commercialization of student-led healthtech ideas. Knowledge Exchange: Faculty, researchers, and industry experts will engage in reciprocal learning and cross-training to fuel innovation, skill-building, and strategic growth. Affaan Shaikh, Founder & CEO of IntelliDent AI, shared his thoughts on the collaboration: 'This partnership is about reimagining healthcare through ethical AI and innovation. We are thrilled to work alongside one of India's top institutions to shape the next generation of AI health leaders.' The MoU was signed by Dr. Giridhar P. Kini, Registrar of MAHE, and Mr. Affaan Shaikh, with active engagement from academic and innovation stakeholders from both organizations. This collaboration underscores IntelliDent AI's mission to scale accessible, AI-powered dental care globally and MAHE's continued commitment to integrating technology, research, and impact-driven education in the healthcare ecosystem. Together, MAHE and IntelliDent AI are building a bold future where education, innovation, and oral health equity intersect.
Al Etihad
18 hours ago
- Al Etihad
Best of ASCO UAE Conference opens in Abu Dhabi with focus on oncology
21 June 2025 15:53 ABU DHABI (WAM)The third edition of the Best of ASCO UAE Conference opened Saturday in Abu by SEHA, part of the PureHealth Group, in collaboration with Tawam Hospital, the event is taking place at Dusit Thani Hotel and continues until Sunday, bringing together a distinguished line-up of oncology experts from around the under licence from the American Society of Clinical Oncology (ASCO), the conference features more than 70 international, regional and local speakers, including oncology leaders from across the Gulf Cooperation Council and the programme includes over 70 scientific papers that have significantly influenced oncology treatment strategies this Julie Gralow, Chief Medical Officer and Executive Vice President of ASCO, told the Emirates News Agency (WAM) that the annual ASCO meeting highlighted key developments, including the use of circulating tumour DNA for diagnosis and the role of artificial intelligence in supporting pathologists with more accurate tumour emphasised the importance of healthy lifestyle habits in improving patient outcomes, citing a recent randomised study that found regular exercise following a colon cancer diagnosis led to reduced recurrence and mortality rates. She underscored the benefits of combining physical activity with a balanced diet and weight loss to enhance treatment also highlighted rapid advances in immunotherapy, particularly in antibody-drug conjugates and immune checkpoint inhibitors, which are now being used in new therapeutic indications and earlier stages of the subject of precision medicine, Gralow explained that the approach aims to identify molecular mutations that transform cells into cancerous forms and to develop treatments that precisely target those mutations. Many such targeted therapies have demonstrated efficacy in treating abnormal cancer-causing Khalid Saeed Balaraj, Chair of the Oncology Centre at Tawam Hospital, and Vice-Chair of the Conference, said the event includes more than seven specialist scientific workshops designed for junior doctors. These sessions aim to equip them for future roles in cancer care and provide valuable opportunities for direct engagement with leading international oncology discussed the emergence of new drugs that have proven effective against various cancers, noting that the conference will explore the potential for incorporating these treatments into formal care protocols, with particular emphasis on advances in treating breast cancer in also pointed to the breakthrough progress in immunotherapies and targeted therapies, which accurately attack tumours while preserving healthy surrounding added that modern medical care is increasingly based on developing individualised treatment plans tailored to each patient's unique biological and molecular profile. This approach can result in different treatment strategies for two patients with the same diagnosis, depending on their respective responses to treatment. He noted that ASCO organises an annual international conference attended by leading oncology scientists and researchers from around the world. Mouza Al Amri, Consultant Breast Surgeon and Acting Director of Breast Cancer Care Centre at Tawam Hospital, announced during the conference the launch of the Emirates Society of Radiation Oncology (ESRO). Based in Abu Dhabi, the society will focus on patient care, continuing medical education in oncology, radiation therapy and cancer surgery. She confirmed that the society's operations officially commenced on Saturday.
